A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Clinical trial NCT07103668 · RECRUITING
Trial details
- NCT number
- NCT07103668
- Sponsor
- Suzhou Immunofoco Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-06
- Primary completion
- 2027-05-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.